PharmaGap fka GAP

[Tackler]

NATIONAL INSTRUMENT 44-101
SHORT FORM PROSPECTUS DISTRIBUTIONS
NOTICE DECLARING INTENTION
TO BE QUALIFIED UNDER
NATIONAL INSTRUMENT 44-101
SHORT FORM PROSPECTUS DISTRIBUTIONS
(“NI 44-101”)
May 12, 2008
To: Ontario Securities Commission
And to: British Columbia Securities Commission
Alberta Securities Commission
Autorité des Marchés Financiers
PharmaGap Inc. (the “Issuer”) intends to be qualified to file a short form prospectus under NI
44-101. The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a
preliminary short form prospectus. This notice does not evidence the Issuer’s intent to file a short
form prospectus, to enter into any particular financing or transaction or to become a reporting issuer
in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer.
PHARMAGAP INC.
By:
Simon Goulet
Chief Operating
Officer